alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### § 182.210 To whom must I distribute my drug-free workplace statement?

You must require that a copy of the statement described in § 182.205 be given to each employee who will be engaged in the performance of any Federal award.
exv10w1






Exhibit 10.1




AMENDMENT ONE

to the

MERCK & CO., INC.

CHANGE IN CONTROL SEPARATION BENEFITS PLAN

(Effective as Amended and Restated as of November 3, 2009)




     WHEREAS, under Section 8.2 of the Merck & Co., Inc. Change in Control Separation Benefits Plan
(the “ CIC Plan”), the CIC Plan may be amended or modified in any respect by resolution
adopted by two-thirds of the Compensation and Benefits Committee of the Board; provided that in the
event of a Change in Control within one year of the amendment, or an MSD Change in Control within
one year of the Merck CIC Plan’s Restatement Date (as such terms are defined in the CIC Plan), the
provisions that were in effect prior to such amendment will apply with respect to those impacted
participants who were participants as of the date of the amendment;



     WHEREAS, the Committee desires to and hereby amends the CIC Plan to provide that Executive
Committee Members who participate in the plan will be treated in the same manner as certain other
executives who participate in the plan with respect to certain tax gross-up benefits that may
otherwise be imposed under Sections 280G and 4999 of the Internal Revenue Code of 1986, as amended
(the “ Code”);



     NOW, THEREFORE, BE IT


RESOLVED, that in consideration of the premises, the CIC Plan is hereby amended, as follows:



1. Section 6.1 of the CIC Plan shall be renamed as “Gross-up Payments” and the preamble for such
section (prior to subsection (a)) is replaced with the following paragraph:





Gross-up Payments. This Section 6.1 is effective from the Effective Date until
February 15, 2010 and shall be applicable solely to Participants who are Executive Committee
Members. Effective on or after February 15, 2010, this Section 6.1 shall no longer be
applicable and any Participants who are Executive Committee Members shall be eligible for
the benefits described in Section 6.2; provided however that if a Change in Control occurs
prior to February 15, 2011, or if an MSD Change in Control occurs prior to the first
anniversary of the Restatement Date (in accordance with Section 7.2(b)), a Participant who
is an Executive Committee Member shall be entitled to the benefits provided in this 6.1 in
lieu of the benefits in 6.2.


2. Section 6.2 of the CIC Plan shall be renamed as “Modified Cap Benefit” and the preamble for such
section (prior to subsection (a)) is replaced with the following paragraph:





Modified Cap Benefit. Effective until February 15, 2010, this Section 6.2 shall be
applicable solely to Participants who are Other Executives. Effective on or after February
15, 2010, subject to Section 6.1, this Section 6.2 shall be applicable to Participants who
are Executive Committee Members or Other Executives.


3. This amendment is effective as of February 15, 2010.
#### § 3001.225 Who in DHS does a recipient other than an individual notify about a criminal drug conviction?

A recipient other than an individual that is required under 2 CFR 182.225(a) to notify Federal agencies about an employee's conviction for a criminal drug offense must notify the DHS Office of Inspector General and each DHS office from which the recipient currently has an award.
IV 

House Calendar No. 156 

115TH CONGRESS 

2D SESSION H. RES. 953 

[Report No. 115–771] 

Providing for consideration of the bill (H.R. 6136) to amend the immigration 

laws and provide for border security, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

JUNE 20, 2018 

Mr. NEWHOUSE, from the Committee on Rules, reported the following resolution; which was referred to the House Calendar and ordered to be printed 

RESOLUTION 

Providing for consideration of the bill (H.R. 6136) to amend 

the immigration laws and provide for border security, 

and for other purposes. 

1 Resolved, That upon adoption of this resolution it 

2 shall be in order to consider in the House the bill (H.R. 

3 6136) to amend the immigration laws and provide for bor4 der security, and for other purposes. All points of order 

5 against consideration of the bill are waived. The bill shall 

6 be considered as read. All points of order against provi7 sions in the bill are waived. The previous question shall 


lotter on DSKBCFDHB2PROD with BILLS
2 

•HRES 953 RH 

1 be considered as ordered on the bill and on any amend2 ment thereto to final passage without intervening motion 

3 except: (1) one hour of debate, with 40 minutes equally 

4 divided and controlled by the chair and ranking minority 

5 member of the Committee on the Judiciary and 20 min6 utes equally divided and controlled by the chair and rank7 ing minority member of the Committee on Homeland Se8 curity; and (2) one motion to recommit. 


lotter on DSKBCFDHB2PROD with BILLS

lotter on DSKBCFDHB2PROD with BILLS
House Calendar No. 156 

115TH CONGRESS 

2D SESSION H. RES. 953 

[Report No. 115–771] 

RESOLUTION 

Providing for consideration of the bill (H.R. 6136) 

border security, and for other purposes. to amend the immigration laws and provide for 

JUNE 20, 2018 

Referred to the House Calendar and ordered to be 

printed 


lotter on DSKBCFDHB2PROD with BILLS
§ 835.602 Controlled areas. ( a ) Each access point to a controlled area (as defined at § 835.2) shall be posted whenever radiological areas or radioactive material areas exist in the area. Individuals who enter only controlled areas without entering radiological areas or radioactive material areas are not expected to receive a total effective dose of more than 0.1 rem (0.001 sievert) in a year.
( b ) Signs used for this purpose may be selected by the contractor to avoid conflict with local security requirements.
[58 FR 65485, Dec. 14, 1993, as amended at 63 FR 59684, Nov. 4, 1998; 72 FR 31926, June 8, 2007]
§ 111.180 Under this subpart G, what records must you make and keep? ( a ) You must make and keep records required under this subpart G in accordance with subpart P of this part.
( b ) You must make and keep the following records: ( 1 ) Written procedures for fulfilling the requirements of this subpart.
( 2 ) Receiving records (including records such as certificates of analysis, suppliers' invoices, and suppliers' guarantees) for components, packaging, and labels and for products that you receive for packaging or labeling as a dietary supplement (and for distribution rather than for return to the supplier); and
( 3 ) Documentation that the requirements of this subpart were met. ( i ) The person who performs the required operation must document, at the time of performance, that the required operation was performed.
( ii ) The documentation must include: ( A ) The date that the components, packaging, labels, or products that you receive for packaging or labeling as a dietary supplement were received;
( B ) The initials of the person performing the required operation;
( C ) The results of any tests or examinations conducted on components, packaging, or labels, and of any visual examination of product that you receive for packaging or labeling as a dietary supplement; and
( D ) Any material review and disposition decision conducted on components, packaging, labels, or products that you receive for packaging or labeling as a dietary supplement.
#### Charles Sorochty et al., Respondents, v. William Caparco et al., Constituting the Rochester Municipal Civil Service Commission, Appellants.

(Appeal No. 2.)

—Judgment unanimously reversed on the law and facts, without costs, and petition dismissed. (Same memorandum as in *Soroohty*v. *Capareo,*34 A D 2d 1090.) (Appeal from supplemental judgment of Monroe Special Term confirming judgment in Appeal No. 1.) Present — Goldman, P. J., Witmer, Gabrielli, Bastow and Henry, JJ.
§ 840.2 Procedures. ( a ) DOE may initiate, on its own motion, the making of a determination as to whether or not there has been an extraordinary nuclear occurrence. In the event DOE does not so initiate the making of a determination, any affected person, or any person with whom an indemnity agreement is executed may petition DOE for a determination of whether or not there has been an extraordinary nuclear occurrence. If DOE does not have, or does not expect to have, within 7 days after it has received notification of an alleged event, enough information available to make a determination that there has been an extraordinary nuclear occurrence, DOE will publish a notice in the Federal Register setting forth the date and place of the alleged event and requesting any persons having knowledge thereof to submit their information to DOE.
( b ) When a procedure is initiated under paragraph (a) of this section, the principal staff which will begin immediately to assemble the relevant information and prepare a report on which the DOE can make its determination will consist of the Directors or their designees of the following Divisions or Offices: Office of Nuclear Safety, Office of Operational Safety, Office of Health and Environmental Research, the General Counsel or his designee, and a representative of the program division whose facility or device may be involved.
IV 

109TH CONGRESS 

2D SESSION H. RES. 784 

Commending and supporting Radio Al Mahaba, Iraq’s first and only radio 

station for women. 

IN THE HOUSE OF REPRESENTATIVES 

APRIL 27, 2006 

Mrs. MCCARTHY (for herself, Mr. OSBORNE, Mrs. TAUSCHER, Ms. GRANGER, 

Ms. SOLIS, Ms. ROS-LEHTINEN, and Mr. ACKERMAN) submitted the following resolution; which was referred to the Committee on International 

Relations 

RESOLUTION 

Commending and supporting Radio Al Mahaba, Iraq’s first 

and only radio station for women. 

Whereas Radio Al Mahaba, Iraq’s first and only radio station 

for women, went on the air on April 1, 2005; 

Whereas Radio Al Mahaba is an educational tool, broadcasting in three different languages and giving women 

freedom to voice opinions and hear other opinions; 

Whereas Radio Al Mahaba airs shows dedicated to women’s 

rights and women’s issues; 

Whereas such shows are devoted to relationships, parenting, 

and other social topics; 

Whereas despite terrible risks, the staff of Radio Al Mahaba 

works at the station because they want to reach out and 


hmoore on PROD1PC68 with HMBILLS
2 

•HRES 784 IH 

touch peoples’ lives, and they want to give hope, knowledge, empowerment, support, and a passage to freedom 

to Iraq women; 

Whereas Radio Al Mahaba, amid the struggles in Iraq, has 

followed the examples of the United States which guarantees freedoms of speech and the press, thereby encouraging Iraqis to build an open, democratic civil society; 

Whereas Radio Al Mahaba has a positive, important role in 

educating women; 

Whereas Radio Al Mahaba provides women with freedom of 

speech; 

Whereas Radio Al Mahaba provides an opportunity for 

women to secure their role in the governance of a civil 

society within Iraq; and 

Whereas Radio Al Mahaba meets a palpable need of Iraqi 

women: Now, therefore, be it 

1 Resolved, That the House of Representatives— 

2 (1) commends the efforts of Radio Al Mahaba 

3 to provide Iraqi women with freedom of speech and 

4 an opportunity for women to be included in and in5 formed of the reconstruction of Iraq with an open, 

6 democratic civil society; 

7 (2) supports the mission of Radio Al Mahaba; 

8 and 

9 (3) urges Al Mahaba to continue its important 

10 work. 

Æ 


hmoore on PROD1PC68 with HMBILLS
§ 1010.3 Identification. ( a ) Every manufacturer of an electronic product to which a standard under this subchapter is applicable shall set forth the information specified in paragraphs (a)(1) and (2) of this section. This information shall be provided in the form of a tag or label permanently affixed or inscribed on such product so as to be legible and readily accessible to view when the product is fully assembled for use or in such other manner as may be prescribed in the applicable standard. Except for foreign equivalent abbreviations as authorized in paragraph (a)(1) of this section all such labels or tags shall be in the English language. ( 1 ) The full name and address of the manufacturer of the product; abbreviations such as “Co.,” “Inc.,” or their foreign equivalents and the first and middle initials of individuals may be used. Where products are sold under a name other than that of the manufacturer of the product, the full name and address of the individual or company under whose name the product was sold may be set forth, provided such individual or company has previously suppled the Director, Center for Devices and Radiological Health with sufficient information to identify the manufacturer of the product.
( 2 ) The place and month and year of manufacture: ( i ) The place of manufacture may be expressed in code provided the manufacturer has previously supplied the Director, Center for Devices and Radiological Health with the key to such code.
( ii ) The month and year of manufacture shall be provided clearly and legibly, without abbreviation, and with the year shown as a four-digit number as follows in this paragraph. Alternatively, a manufacturer may utilize a manufacturing symbol and date format that conforms with an applicable FDA recognized consensus standard. Manufactured: (Insert Month and Year of Manufacture.)
( b ) In the case of products for which it is not feasible to affix identification labeling in accordance with paragraph (a) of this section, upon application by the manufacturer, the Director, Center for Devices and Radiological Health may approve an alternate means by which such identification may be provided.
( c ) Every manufacturer of an electronic product to which a standard under this subchapter is applicable shall provide to the Director, Center for Devices and Radiological Health a list identifying each brand name which is applied to the product together with the full name and address of the individual or company for whom each product so branded is manufactured.
[40 FR 32257, July 31, 1975, as amended at 42 FR 18063, Apr. 5, 1977; 53 FR 11254, Apr. 6, 1988; 88 FR 3653, Jan. 20, 2023]
§ 75.46 Expenses. ( a ) Under the Safeguards Agreements, the IAEA undertakes to reimburse any person subject to this part for extraordinary expenses incurred as a result of its specific request provided that the IAEA has agreed in advance to do so. The Safeguards Agreements also provide that the IAEA will reimburse that person for the cost of making additional measurements or taking samples at the specific request of an IAEA inspector.
( b ) The NRC will inform persons subject to this part, by license condition or by other means (e.g., written communication), of those items of extraordinary expense that the IAEA has agreed in advance to reimburse.
( c ) The NRC will inform persons subject to this part, by license condition or by other means (e.g., written communication), of the procedures to be used to document: ( 1 ) An IAEA inspector's request for making additional measurements or taking additional samples; and
( 2 ) An IAEA request for a particular action by the licensee that will give rise to reimbursable extraordinary expense.
( d ) The NRC will take appropriate action to assist persons subject to this part regarding the reimbursement of any expense that, under the Safeguards Agreements, is to be borne by the IAEA.
[45 FR 50711, July 31, 1980, as amended at 73 FR 78614, Dec. 23, 2008; 83 FR 19614, May 4, 2018]
Editorial Note on Part 102
Editorial Note: Nomenclature changes to part 102 appear at 81 FR 49895, July 29, 2016.

§ 102.41 Potato chips made from dried potatoes. ( a ) The common or usual name of the food product that resembles and is of the same composition as potato chips, except that it is composed of dehydrated potatoes (buds, flakes, granules, or other form), shall be “potato chips made from dried potatoes.”
( b ) The words “made from dried potatoes” shall immediately follow or appear on a line(s) immediately below the words “potato chips” in easily legible boldface print or type in distinct contrast to other printed or graphic matter, and in a height not less than the larger of the following alternatives: ( 1 ) Not less than one-sixteenth inch in height on packages having a principal display panel with an area of 5 square inches or less and not less than one-eighth inch in height if the area of the principal display panel is greater than 5 square inches; or
( 2 ) Not less than one-half the height of the largest type used in the words “potato chips.”
§ 1.1107 When must food testing be conducted under this subpart? ( a ) Food testing must be conducted under this subpart whenever such testing is conducted by or on behalf of an owner or consignee: ( 1 ) In response to explicit testing requirements that address an identified or suspected food safety problem, which are contained in the following provisions: ( i ) *Sprouts.* Section 112.146(a), (c), and (d) of this chapter;
( ii ) *Shell eggs.* Sections 118.4(a)(2)(iii), 118.5(a)(2)(ii) and (b)(2)(ii), and 118.6(a)(2) and (e) of this chapter; and
( iii ) *Bottled drinking water.* Section 129.35(a)(3)(i) of this chapter (for the requirement to test five samples from the same sampling site that originally tested positive for *Escherichia coli*);
( 2 ) As required by FDA in a directed food laboratory order issued under § 1.1108;
( 3 ) To address an identified or suspected food safety problem and presented to FDA as part of evidence for a hearing under section 423(c) of the Federal Food, Drug, and Cosmetic Act prior to the issuance of a mandatory food recall order, as part of a corrective action plan under section 415(b)(3)(A) of the Federal Food, Drug, and Cosmetic Act submitted after an order suspending the registration of a food facility, or as part of evidence submitted for an appeal of an administrative detention order under section 304(h)(4)(A) of the Federal Food, Drug, and Cosmetic Act.
( 4 ) In support of admission of an article of food under section 801(a) of the Federal Food, Drug, and Cosmetic Act; and
( 5 ) To support removal from an import alert through successful consecutive testing.
( b ) When food testing is conducted under paragraph (a) of this section, analysis of samples must be conducted by a laboratory that is LAAF-accredited for the appropriate analytical method by a recognized accreditation body under this subpart.
( c ) Food testing conducted on articles of food offered for import into the United States under section 801(a) of the Federal Food, Drug, and Cosmetic Act pursuant to paragraph (a)(4) or (a)(5) of this section may only be conducted after the articles offered for import have arrived in the United States unless the owner or consignee has written approval from FDA that a sample taken prior to arrival is or would be a representative sample of the article offered for import into the United States.
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          SEP-30-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               MAR-31-1998
<CASH>                                           1,450
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                      6,525
<CURRENT-ASSETS>                                 7,975
<PP&E>                                       1,570,833
<DEPRECIATION>                                 299,975
<TOTAL-ASSETS>                               1,278,833
<CURRENT-LIABILITIES>                          298,182
<BONDS>                                        359,620
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        23,910
<OTHER-SE>                                     597,121
<TOTAL-LIABILITY-AND-EQUITY>                 1,278,833
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                33,455
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               6,121
<INCOME-PRETAX>                               (39,576)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (39,576)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (39,576)
<EPS-PRIMARY>                                   (0.00)
<EPS-DILUTED>                                   (0.00)
        

</TABLE>
COURT OF APPEALS

EIGHTH DISTRICT OF TEXAS

EL PASO, TEXAS

MANUEL TORRES,

Appellant,

v.

THE STATE OF TEXAS,

Appellee. §

§

§

§

§

§ No. 08

- 12

- 00096

- CR

Appeal from

County Criminal Court No. 4

of El Paso County, Texas

(TC # 20090C07495)

J U D G M E N T

The Court has considered this cause on the record and concludes there was error in the

judgment. We therefore reverse the judgment of the trial court and remand the cause for new

trial, in accordance with the opinion of this Court, and that this decision be certified below for

observation.

IT IS SO ORDERED THIS 18TH DAY OF SEPTEMBER, 2014.

ANN CRAWFORD McCLURE, Chief Justice

Before McClure, C.J., Rivera, and Rodriguez, JJ.

(Rivera, J., not partic ipating)
1

In The

Court of Appeals

Ninth District of Texas at Beaumont

__________________

NO. 09-19-00371-CV

__________________

CHRISTINA WINTERS, Appellant

V.

JACOBO ARREGUIN RIVERA, Appellee

__________________________________________________________________

On Appeal from the 284th District Court

Montgomery County, Texas

Trial Cause No. 18-07-09703-CV

__________________________________________________________________

MEMORANDUM OPINION

On December 4, 2019, we notified the parties that this appeal would be 

dismissed unless the appellant remitted the filing fee for the appeal. Appellant did 

not respond.

Appellant did not file an affidavit of indigence on appeal and has not shown

that she is entitled to proceed without payment of costs. See Tex. R. App. P. 20.1. 
2

There being no satisfactory explanation for the failure to pay the filing fee for the 

appeal, the appeal is dismissed for want of prosecution. See Tex. R. App. P. 42.3.

APPEAL DISMISSED.

PER CURIAM

Submitted on January 15, 2020

Opinion Delivered January 16, 2020

Before McKeithen, C.J., Kreger and Johnson, JJ.